Panagora Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,286
Closed -$1M 1367
2023
Q1
$1M Buy
4,286
+1,672
+64% +$423K 0.01% 837
2022
Q4
$658K Sell
2,614
-628
-19% -$134K ﹤0.01% 1055
2022
Q3
$575K Buy
+3,242
New +$651K ﹤0.01% 1092
2019
Q4
Sell
-46,317
Closed -$2.83M 2514
2019
Q3
$2.83M Hold
46,317
0.01% 632
2019
Q2
$2.81M Buy
+46,317
New +$2.5M 0.01% 692

Other funds holding INSP

Panagora Asset Management's INSP Position: Q2 2023 in Review

Panagora Asset Management sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 4,286 shares — an estimated $1M sold.

Panagora Asset Management first reported a position in INSP in Q2 2019 and held it in 5 quarters. The position peaked at $2.83M in Q3 2019. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

  • Panagora Asset Management reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
  • Panagora Asset Management sold 4,286 Inspire Medical Systems shares in Q2 2023, an estimated $1M.
  • Panagora Asset Management first reported a position in Inspire Medical Systems in Q2 2019 and held it in 5 quarters.
  • Panagora Asset Management's Inspire Medical Systems position peaked at $2.83M in Q3 2019.
  • 407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.